WO2023105460 - CO-CRYSTALS OF UPADACITINIB
National phase entry is expected:
Publication Number
WO/2023/105460
Publication Date
15.06.2023
International Application No.
PCT/IB2022/061932
International Filing Date
08.12.2022
Title **
[English]
CO-CRYSTALS OF UPADACITINIB
[French]
CO-CRISTAUX D'UPADACITINIB
Applicants **
METROCHEM API PVT LTD.
Inventors
NANDEPU, Venkateswara Rao
NANDEPU, Hardev
SOMISETTI, Narender Rao
BIJJULA, Venkata Krishna Reddy
Priority Data
202141057042
08.12.2021
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP India
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1978 | |
| EPO | Filing, Examination, Granting | 11240 | |
| Japan | Filing, Examination, Granting | 2079 | |
| South Korea | Filing, Examination, Granting | 1854 | |
| USA | Filing, Examination, Granting | 5940 |
Total:
23,091
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention relates to co-crystals of Upadacitinib, process for its preparation and pharmaceutical composition comprising the same.[French]
La présente invention concerne des co-cristaux d'Upadacitinib, un procédé pour sa préparation et une composition pharmaceutique les comprenant.